Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Marvin, Rubenstein"'
Publikováno v:
Therapeutic Advances in Urology, Vol 5 (2013)
Background: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth regulatory proteins. While most oligos have targeted growth factors or their receptors, others have been directed
Externí odkaz:
https://doaj.org/article/adffa41532a34197ab67071c89d45f6e
Autor:
Mukesh Kumar Chaubey, Hugo Gael Ramírez-Villalobos, T. R. Prashith Kekuda, Hayder A. Kadhim, K. Ramesh, Aymen Hameed Uraibi, Turki A. Al-Mogbel, Amjad Al-Asadi, Shamima Nasren, Monerh H. Al-Abdullatif, Ankur Upadhyay, Hasan Sabah Hasan, Abid Mehmood, Pragna Parikh, Parth Pandya, Simone Aparecida Galerani Mossini, Carla Cristina Arrotéia, Carlos Kemmelmeier, Amal H Al-Najjar, Jerrine Joseph, Umer Hafeez Goursi, V. N. Yogananda Murthy, Ernesto A. Chávez, V. N. Murulidhara, Malik Rapaie, A. Usha Raja Nanthini, Arkan Muslim Al Azzawi, Hassan H. Mohammed, Angamuthu Vignesh, Jemimah Ayuma Simbauni, Rehab M Elgharabawy, Amira S. Ahmed, Kaari Manigundan, KS Vinayaka, S. Jalajakshi, Venugopal Gopikrishnan, Md. Abdullah Al Mamun, Mona A. Al-Abdullatif, Muzahim M. Abdullah, Marvin Rubenstein, S. S. Rathore, Manikkam Radhakrishnan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a86e19223b8d679db781a674ad2cbc6
https://doi.org/10.9734/bpi/rrab/v1
https://doi.org/10.9734/bpi/rrab/v1
Publikováno v:
Therapeutic Advances in Urology, Vol 3 (2011)
Background: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth stimulatory gene products. While most oligos have targeted growth factors or their receptors, others have been dir
Externí odkaz:
https://doaj.org/article/bf97793f1ff645caa4bc4d6d3ceded26
Publikováno v:
Therapeutic Advances in Urology, Vol 3 (2011)
Background and methods: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth stimulatory gene products. While most oligos have targeted growth factors or their receptors, others h
Externí odkaz:
https://doaj.org/article/4e808a7e84bf49808fb4f1b5c809e251
Autor:
Marvin Rubenstein
Publikováno v:
Cancer Science & Research. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e4e66cc3dff3280a73a3964d10aae41
https://doi.org/10.33425/2639-8478.1031
https://doi.org/10.33425/2639-8478.1031
Autor:
Marvin Rubenstein
Publikováno v:
Cancer Science & Research. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7ca03384c77b5f79b2fe1e83544b53f
https://doi.org/10.33425/2639-8478.1022
https://doi.org/10.33425/2639-8478.1022
Autor:
Marvin Rubenstein
Publikováno v:
SPG BioMed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9928b485a66e932591e4e3f618affcb
https://doi.org/10.32392/biomed.9
https://doi.org/10.32392/biomed.9
Publikováno v:
Open Journal of Apoptosis. :62-70
Antisense oligonucleotides (oligos) have targeted growth regulatory proteins in prostate cancer models. To identify compensatory alterations in the expression of non-targeted genes we evaluate mono- and bispecific oligos targeting and equally suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9e1137f43a8860375f66dfa12938b81
https://doi.org/10.4236/ojapo.2015.43007
https://doi.org/10.4236/ojapo.2015.43007
Publikováno v:
Open Journal of Apoptosis. :1-10
Previously we have shown that when LNCaP cells are treated with antisense oligonucleotides (oligos) directed against BCL-2, compensatory changes in non-targeted genes take place in attempts to restore apoptosis and promote tumor aggressiveness. In ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6024964a684f1c1185007ab7eecc6701
https://doi.org/10.4236/ojapo.2015.41001
https://doi.org/10.4236/ojapo.2015.41001
Publikováno v:
Cancer Science & Research: Open Access. 1:1-7
Antisense oligonucleotides (oligos) have been administered against prostatic LNCaP cells in both in vivo and in vitro models. While most oligos consist of a single mRNA binding site targeting a single gene product, or others having sequence homology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba915c82e845006973c807c92dec973d
https://doi.org/10.15226/csroa.2014.00108
https://doi.org/10.15226/csroa.2014.00108